JP2024511452A5 - - Google Patents
Info
- Publication number
- JP2024511452A5 JP2024511452A5 JP2023558499A JP2023558499A JP2024511452A5 JP 2024511452 A5 JP2024511452 A5 JP 2024511452A5 JP 2023558499 A JP2023558499 A JP 2023558499A JP 2023558499 A JP2023558499 A JP 2023558499A JP 2024511452 A5 JP2024511452 A5 JP 2024511452A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- methyl
- isobutyl
- formula
- thienyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2104038.1 | 2021-03-23 | ||
| GBGB2104038.1A GB202104038D0 (en) | 2021-03-23 | 2021-03-23 | New compounds |
| PCT/GB2022/050726 WO2022200786A1 (en) | 2021-03-23 | 2022-03-23 | Selective angiotensin ii receptor ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511452A JP2024511452A (ja) | 2024-03-13 |
| JP2024511452A5 true JP2024511452A5 (https=) | 2025-03-31 |
Family
ID=75689746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558499A Pending JP2024511452A (ja) | 2021-03-23 | 2022-03-23 | 選択的アンジオテンシンｉｉ受容体リガンド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240174657A1 (https=) |
| EP (1) | EP4313976A1 (https=) |
| JP (1) | JP2024511452A (https=) |
| CN (1) | CN117203204A (https=) |
| CA (1) | CA3212780A1 (https=) |
| GB (1) | GB202104038D0 (https=) |
| WO (1) | WO2022200786A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202104033D0 (en) * | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| IE20230600A3 (en) | 2022-12-22 | 2025-09-24 | Vicore Pharma Ab | A method of treating a patient diagnosed with an interstitial lung disease |
| EP4648850A1 (en) * | 2023-01-09 | 2025-11-19 | Vicore Pharma AB | Selective angiotensin ii compounds |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312820A (en) | 1992-07-17 | 1994-05-17 | Merck & Co., Inc. | Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines |
| US5444067A (en) | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A & Science Invest Ab | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| CN1529697B (zh) | 2001-05-31 | 2010-09-22 | 维科尔药物公司 | 用作血管紧张素ⅱ激动剂的三环化合物 |
| JP4707321B2 (ja) * | 2001-05-31 | 2011-06-22 | ヴィコール・ファルマ・アーベー | アンギオテンシンｉｉアゴニストとして有用な三環式化合物 |
| WO2003064414A1 (en) * | 2002-01-29 | 2003-08-07 | Vicore Pharma Ab. | Tricyclic compounds useful as angiotensin ii agonists |
| AU2003302106A1 (en) | 2002-11-21 | 2004-06-15 | Vicore Pharma Ab | New tricyclic angiotensin ii agonists |
| US8835471B2 (en) | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
| BR112017012337A2 (pt) | 2014-12-12 | 2018-02-27 | Vicore Pharma Ab | Método para tratamento de doença falciforme, agonista do receptor at2, ou um sal farmaceuticamente aceitável, solvato ou pró- fármaco do mesmo, uso de um agonista do receptor at2, ou um sal farmaceuticamente aceitável, solvato ou pró-fármaco do mesmo, formulação farmacêutica, e, produto de combinação. |
| WO2016107879A2 (en) | 2014-12-30 | 2016-07-07 | Vicore Pharma Ab | New use of angiotensin ii receptor agonists |
| EP3265082A1 (en) | 2015-03-02 | 2018-01-10 | Vicore Pharma AB | Angiotensin ii receptor agonist for treating pulmonary fibrosis |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| GB201710906D0 (en) | 2017-07-06 | 2017-08-23 | Vicore Pharma Ab | Compounds and methods for treating peripheral neuropathy |
| GB201913603D0 (en) * | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| GB202013721D0 (en) * | 2020-09-01 | 2020-10-14 | Vicore Pharma Ab | New compounds |
-
2021
- 2021-03-23 GB GBGB2104038.1A patent/GB202104038D0/en not_active Ceased
-
2022
- 2022-03-23 CA CA3212780A patent/CA3212780A1/en active Pending
- 2022-03-23 JP JP2023558499A patent/JP2024511452A/ja active Pending
- 2022-03-23 EP EP22714510.9A patent/EP4313976A1/en active Pending
- 2022-03-23 US US18/283,487 patent/US20240174657A1/en active Pending
- 2022-03-23 WO PCT/GB2022/050726 patent/WO2022200786A1/en not_active Ceased
- 2022-03-23 CN CN202280030667.9A patent/CN117203204A/zh active Pending